Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/1996
08/15/1996WO1996024848A1 Monoclonal antibodies for human osteogenic cell surface antigens
08/15/1996WO1996024846A1 Human t cell inositol 1,4,5-trisphosphate receptor
08/15/1996WO1996024675A1 GnRH-LEUKOTOXIN CHIMERAS
08/15/1996WO1996024673A1 Mucosal vascular addressins and uses thereof
08/15/1996WO1996024671A1 Multispecific chimeric receptors
08/15/1996WO1996024668A1 Human chemokine beta-11 and human chemokine alpha-1
08/15/1996WO1996024603A1 InK4c-p18 AND InK4D-p19, INHIBITORS OF CYCLIN-DEPEDENT KINASES CDK4 AND CDK6, AND USES THEREOF
08/15/1996WO1996024357A1 Novel glucocorticoid response elements
08/15/1996WO1996018738A3 PROBIN TYROSINE KINASE (PYK2) ITS cDNA CLONING AND ITS USES
08/15/1996WO1996015144A3 Chromosome 21 gene marker, compositions and methods using same
08/15/1996WO1996013590A3 New sequences of hepatitis c virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
08/15/1996WO1996012019A3 Her4 human receptor tyrosine kinase or the epidermal growth factor receptor family
08/15/1996CA2221571A1 Multispecific chimeric receptors
08/15/1996CA2212379A1 Novel glucocorticoid response elements
08/15/1996CA2212376A1 Ink4c-p18 and ink4d-p19, inhibitors of cyclin-dependent kinases cdk4 andcdk6, and uses thereof
08/15/1996CA2212054A1 Gnrh-leukotoxin chimeras
08/15/1996CA2210471A1 Human chemokine beta-11 and human chemokine alpha-1
08/14/1996EP0726324A2 Use of exonuclease and/or glycosylase as supplements to anti-polymerase antibody to increase specificity in polymerase chain reaction
08/14/1996EP0726315A1 Epstein-Barr virus DNA sequences encoding a diagnostically relevant virus capsid antigen, expression clones derived through polymerase chain reaction and the use of this recombinant antigen in diagnostic tests
08/14/1996EP0726314A1 FIMBRILLIN PROTEIN OF $i(PORPHYROMONAS GINGIVALIS)
08/14/1996EP0726277A2 Anti-ribonucleotide reductase R2 subunit monoclonal antibody
08/14/1996EP0726275A1 Benzodiazepine protein conjugates and their use in benzodiazepine immunoassays
08/14/1996EP0725837A1 Adeno-associated virus - its diagnostic use with early abortion
08/14/1996EP0725833A1 Prenatal diagnosis by isolation of fetal granulocytes from maternal blood
08/14/1996EP0725832A1 Transfection process
08/14/1996EP0725829A1 Methods and compositions for high protein production from recombinant dna
08/14/1996EP0725825A1 Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains
08/14/1996EP0725800A1 cDNA ENCODING A NOVEL HUMAN PROTEIN TYROSINE PHOSPHATASE
08/14/1996EP0725799A1 A novel tumor marker and novel method of isolating same
08/14/1996EP0725798A1 Type i angiotensin ii receptor specific monoclonal antibodies and hybridomas
08/14/1996EP0725796A1 Growth differentiation factor-10
08/14/1996EP0725792A1 RECOMBINANT PilC PROTEINS, PROCESS FOR PRODUCING THEM AND THEIR USE
08/14/1996EP0725789A1 Method of obtaining immunoglobulins from colostrum and their use in pharmaceutical composition
08/14/1996EP0725655A1 Platelet-specific chimeric immunoglobulin and methods of use therefor
08/14/1996EP0725654A1 Pharmaceutical composition comprising monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
08/14/1996EP0725649A1 Class i mhc modulation of surface receptor activity
08/14/1996EP0595794B1 Cloned genes which encode elam-1 and fusion proteins thereof, the protein products expressed therefrom, pharmaceutical compositions and the use thereof
08/14/1996EP0575317B1 Recombinant anticoccidial vaccine
08/14/1996EP0457804B1 M-csf monoclonal antibodies that recognize a neutralizing conformational epitope
08/14/1996EP0456790B1 Antibody variable domain conjugates
08/14/1996CN1129013A New growth-differentiation factor of the TGF-beta family
08/14/1996CN1128935A Wild-type multiple tumour suppressor (MTS) gene and mutant sequences-useful in diagnosis, prognosis and therapy of human cancer e.g. melanoma or leukaemia
08/13/1996US5545807 Production of antibodies from transgenic animals
08/13/1996US5545806 Ransgenic non-human animals for producing heterologous antibodies
08/13/1996US5545739 Chemiluminescent phenanthridinium salts
08/13/1996US5545721 Reacting crosslinker derivatized antibiotic with crosslinker derivatized immunoglobulin to form conjugate which bonds to surface of microorganisms
08/13/1996US5545718 Synthetic peptides of the conjugate of ubiquitine and H2A histone
08/13/1996US5545616 Method for predicting and/or preventing preterm labor
08/13/1996US5545569 Immobilizing capture moiety that binds transforming growth factor-beta, adding serum from patient to form capture complex, adding labeled signal moiety that binds with complex, determining detectable label, presence of factor
08/13/1996US5545565 Chimeric gene comprising dna fragment encoding insecticidal bacillus thuringiensis toxin, promoter region of gene naturally expressed in plant cells
08/13/1996US5545551 Cloning and expression of pur protein
08/13/1996US5545550 Human virus associated with chronic fatigue immune deficiency syndrome and assay therefore
08/13/1996US5545549 DNA encoding a human neuropeptide Y/peptide YY (Y2) receptor and uses thereof
08/13/1996US5545533 Testing malignancy of tumor selected from hematopoietic cells, seminomas and small-celled lung carcinoma, comprising incubating tissue sample with monoclonal antibody aginst c-kit receptor, detecting bound antibody
08/13/1996US5545532 Human carcinoma antigen (HCA), HCA antibodies, HCA immunoassays and methods of imaging
08/13/1996US5545405 Administering recombinant antibody glycosylated by chinese hamster ovary cell
08/13/1996US5545404 Method for treating a mammal suffering from a T-cell medicated disorder with a CHO-Glycosylated antibody
08/13/1996US5545403 Method for treating a mammal by administering a CHO-glycosylated antibody
08/13/1996CA1338518C Antibody heteroconjugates for the killing of hiv-infected cells
08/10/1996CA2169122A1 Removal of viruses from protein solutions by ultrafiltration
08/08/1996WO1996023885A1 Mycobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis
08/08/1996WO1996023882A1 IDENTIFICATION OF DEC, (DENTRITIC AND EPITHELIAL CELLS, 205 kDa), A RECEPTOR WITH C-TYPE LECTIN DOMAINS, NUCLEIC ACIDS ENCODING DEC, AND USES THEREOF
08/08/1996WO1996023816A1 Radiolabelled proteins
08/08/1996WO1996023815A1 Ob gene product antibodies
08/08/1996WO1996023809A1 Neuropeptide y receptor
08/08/1996WO1996023410A1 UBIQUITIN CONJUGATING ENZYMES 7, 8 and 9
08/08/1996WO1996015244A3 Sensory and motor neuron derived factor (smdf)
08/08/1996DE19521046C1 DNA encoding DNase and related vectors, host cells and antibodies
08/08/1996DE19504755A1 New antibodies against HIV antigens
08/08/1996DE19503146A1 Antibodies to N terminus of collagen 1 alpha2 chain
08/08/1996CA2212225A1 Neuropeptide y receptor
08/08/1996CA2211993A1 Identification of dec, (dentritic and epithelial cells, 205 kda), a receptor with c-type lectin domains, nucleic acids encoding dec, and uses thereof
08/08/1996CA2211713A1 Human peroxisome proliferator activated receptors
08/08/1996CA2210928A1 Mycobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis
08/08/1996CA2169024A1 Anti-ribonucleotide reductase r2 subunit monoclonal antibody
08/08/1996CA2168712A1 Use of exonuclease and/or glycosylase as supplements to anti-polymerase antibody to increase specificity in polymerase chain reaction
08/07/1996EP0725081A1 MONOCLONAL ANTIBODY AGAINST HUMAN Mx PROTEIN MxA
08/07/1996EP0724651A1 Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus
08/07/1996EP0724646A1 Dna sequences related to isolated fragile x syndrome
08/07/1996EP0724644A1 Dna encoding 1,3-beta-d glucan synthase subunits
08/07/1996EP0724632A1 Stem cell proliferation factor
08/07/1996EP0724602A1 MONOCLONAL IgA ANTIBODY AGAINST RESPIRATORY SYNCYTIAL VIRUS
08/07/1996EP0724599A1 Platelet-derived growth factor analogues
08/07/1996EP0724597A1 Ks-laminin and methods of use
08/07/1996EP0724594A1 Regulation of transcription factor, nf-il6/lap
08/07/1996EP0724593A1 Coiled-coil stem loop templates
08/07/1996EP0724588A1 Drug binding protein
08/07/1996EP0724456A1 Antibodies to cd40
08/07/1996EP0724455A1 Method for expression and purification of p2 protein from haemophilus influenzae type b
08/07/1996EP0724453A1 The cloning of duffy blood group antigen
08/07/1996EP0527813B1 T-CEL LYMPHOMA cDNA CLONES
08/07/1996CN1128538A Tandem synthetic HIV-1 peptides
08/06/1996US5543524 Forming a sulfonamide from and amine and a sulfonyl halide and and acylating with a carbonyl halide of an activated acridine salt
08/06/1996US5543503 Antiinflammatory agents
08/06/1996US5543499 Genetic engineering
08/06/1996US5543399 Cystic fibrosis transmembrane conductance regulator (CFTR) protein
08/06/1996US5543145 Pharmaceutical composition and method for the suppression of factor VIII inhibitor production
08/06/1996US5543144 Treating hypersensitivities with anti-IGE monoclonal antibodies which bind to IGE-expressing B cells but not basophils
08/06/1996US5543143 Method for activating macrophages/monocytes
08/01/1996WO1996023225A1 Recombinant c140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor
1 ... 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 ... 1494